The pathology of experimental anthrax in rabbits exposed by inhalation and subcutaneous inoculation

Archives of Pathology and Laboratory Medicine

Volumn 122, Issue 11, 1998, Pages 982-992

  Zaucha, Gary M ^a,b   Pitt, M Louise M ^a   Estep, James ^a   Ivins, Bruce E ^a   Friedlander, Arthur M ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTHRAX; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL SPORE; BLEEDING; COLONY FORMING UNIT; CONTROLLED STUDY; EDEMA; EXPOSURE; FEMALE; INHALATION; INOCULATION; LD 50; LYMPH NODE; MALE; MEDIASTINITIS; NONHUMAN; PNEUMONIA; RABBIT; SUBCUTANEOUS TISSUE;

ADMINISTRATION, INHALATION; AEROSOLS; ANIMALS; ANTHRAX; BACILLUS ANTHRACIS; DISEASE MODELS, ANIMAL; FEMALE; INJECTIONS, SUBCUTANEOUS; LETHAL DOSE 50; LYMPH NODES; MALE; MEDIASTINITIS; RABBITS; SKIN; SURVIVAL RATE;

EID: 0031743296     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Friedlander AM, Welkos SL, Pitt MLM, et al. Postexposure prophylaxis against experimental inhalation anthrax. J Infect Dis. 1993;167:1239-1242.
2. Franz DR, Jahrling PB, Friedlander AM, et al. Clinical recognition and management of patients exposed to biological warfare agents. JAMA. 1997;278:399-411.
3. Zilinskas RA. Iraq's biological weapons: the past as future? JAMA. 1997; 278:418-424.
4. Ivins BE, Fellows P, Pitt L, et al. Experimental anthrax vaccines: efficacy of adjuvants combined with protective antigen against an aerosol Bacillus anthracis spore challenge in guinea pigs. Vaccine. 1995;13:1779-1784.
5. Ivins BE, Fellows PF, Pitt MLM, et al. Efficacy of a standard human anthrax vaccine against Bacillus anthracis aerosol spore challenge in rhesus monkeys. Salisbury Med Bull. 1996;87:125-126.
6. Ivins BE, Welkos SL, Knudson GB, Little SF. Immunization against anthrax with aromatic compound-dependent (Aro) mutants of Bacillus anthracis and with recombinant strains of Bacillus subtilis that produce anthrax protective antigen. Infect Immun. 1990;58:303-308.
7. Ivins BE, Welkos SL, Little SF, Crumrine MH, Nelson GO. Immunization against anthrax with Bacillus anthracis protective antigen combined with adjuvants. Infect Immun. 1992;60:662-668.
8. Ivins BE, Fellows PF, Nelson GO. Efficacy of a standard human anthrax vaccine against Bacillus anthracis spore challenge in guinea pigs. Vaccine. 1994; 12:872-874.
9. Little SF, Knudson GB. Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig. Infect Immun. 1986;52:509-512.
10. Turnbull PBC, Broster MG, Carman JA, Manchee RJ, Melling J. Development of antibodies to protective antigen and lethal factor components of anthrax toxin in humans and guinea pigs and their relevance to protective immunity. Infect Immun. 1986;52:356-363.
11. Turnbull PCB. Anthrax vaccines: past, present and future. Vaccine. 1991; 9:533-539.
12. Fritz DL, Jaax NK, Lawrence WB, et al. Pathology of experimental inhalation anthrax in the rhesus monkey. Lab Invest. 1995;73:691-702.
13. Brachman PS. Inhalation anthrax. Ann N Y Acad Sci. 1980;353:83-93.
14. Cown WB, Kethley TW, Fincher EL. The critical orifice liquid impinger as a sampler for bacterial aerosols. Appl Microbiol. 1957;5:119-124.
15. May KR. The Collison nebulizer, description, performance and applications. J Aerosol Sci. 1973;4:235-243.
16. Prophet EB, Mills B, Arrington JB, Sobin LH, eds. Laboratory Methods in Histopathology. Washington, DC: American Registry of Pathology; 1992.
17. Abramova AA, Grinberg LM. Pathological anatomy of anthracic sepsis based on materials from the infectious outbreak of 1979 in Sverdlovsk (some problems of morpho- and pathogenesis). Arkh Patol. 1993;55:23-26.
18. Cowdery JS. Primary pulmonary anthrax with septicemia. Arch Pathol. 1947;43:396-399.
19. Abramova FA, Grinberg LM, Yampolskaya OV, Walker DH. Pathology of inhalation anthrax in 42 cases from the Sverdlovsk outbreak of 1979. Proc Natl Acad Sci U S A. 1993;90:2291-2294.
20. Albrink WS, Brooks SM, Biron RE, Kopel M. Human inhalation anthrax, a report of three fatal cases. Am J Pathol. 1960;36:457-468.
21. Enticknap JB, Galbraith NS, Tomlinson AJH, Elias-Jones TF. Pulmonary anthrax caused by contaminated sacks. Br J Indust Med. 1968;25:72-74.
22. Tsai-Tung W, Pei-Lin L. Autopsy reports on five fatal cases of anthrax infection: report of International Science Commission. 1952:405-416.
23. Spear J. Report on the So-Called Woolsorters' Disease. Tenth Annual Report, Local Government Board, London, 1880-1881. 1881:66-135.
24. Severn M. A fatal case of pulmonary anthrax. BMJ. 1976;1:748.
25. Plotkin SA, Brachman PS, Utell M, Bumford FH, Atchison MM. An epidemic of inhalation anthrax, the first in the 20th century. I. Clinical features. Am J Med. 1960;29:992-1001.
26. Greenfield W. Supplementary Report on the Woolsorters' Disease in the Bradford District. Eleventh Annual Report of Medical Officers Local Government Board, London. 1882:207-238.
27. Berdjis CC, Gleiser CA, Hartman HA, Kuehne RW, Gochenour WS. Pathogenesis of respiratory anthrax in Macaca mulatta. Br J Exp Pathol. 1962;43:515-524.
28. Berdjis CC, Gleiser CA, Hartman HA. Experimental parenteral anthrax in Macaca mulatta. Br J Exp Pathol. 1963;44:101-115.
29. Gleiser CA, Berdjis CC, Hartman HA, Gochenour WS. Pathology of experimental respiratory anthrax in Macaca mulatta. Br J Exp Pathol. 1963;44:416-426.
30. Ross JM. The pathogenesis of anthrax following the administration of spores by the respiratory route. J Pathol Bacteriol. 1957;73:485-494.
31. Lincoln RE, Hodges DR, Klein F, et al. Role of the lymphatics in the pathogenesis of anthrax. J Infect Dis. 1965;115:481-494.
32. Brachman PS. Anthrax. In: Evans AS, Brachman PS, eds. Bacterial Infections of Humans. 2nd ed. New York, NY: Plenum Medical Book Co; 1991:75-86.
33. Abramova AA, Grinberg LM. Pathological anatomy of anthracic sepsis based on materials from the infectious outbreak of 1979 in Sverdlovsk (macroscopic changes). Arkh Patol. 1993;55:12-17.
34. Hebel R, Stromberg MW. Anatomy of the Laboratory Rat. Baltimore, Md: Williams & Wilkins; 1976:112-118.
35. Cooper G, Schiller AL. Anatomy of the Guinea Pig. Cambridge, Mass: Harvard University Press: 1975:213-221.
36. Miller ME, Christensen GC, Evans HE. Anatomy of the Dog. Philadelphia, Pa: WB Saunders Co; 1964:440-443.
37. Meselson M, Guillemin J, Hugh-Jones M, et al. The Sverdlovsk anthrax outbreak of 1979. Science. 1994;266:1202-1208.
38. Gleiser CA. Pathology of anthrax infection in animal hosts. Fed Proc. 1967; 26:1518-1521.
39. Abramova AA, Grinberg LM. Pathological anatomy of anthracic sepsis based on materials from the infectious outbreak of 1979 in Sverdlovsk (microscopic changes). Arkh Patol. 1993;55:18-23.
40. Harper GJ, Morton JD. The respiratory retention of bacterial aerosols: experiments with radioactive spores. J Hyg. 1953;51:372-385.
41. Dungworth DL. The respiratory system. In: lubb KVF, Kennedy PC, Palmer N, eds. Pathology of Domestic Animals. Vol 2, 3rd ed. San Diego, Calif: Academic Press Inc; 1985:413-556.
42. Albrink WS. Pathogenesis of inhalation anthrax. Bact Rev. 1961;25:268-273.
43. Barnes JM. The development of anthrax following the administration of spores by inhalation. Br J Exp Pathol. 1947;28:385-394.
44. Cromartie WJ, Bloom WL, Watson DW. Studies on infection with Bacillus anthracis. I. Histopathologic study of skin lesions produced by B. anthracis in susceptable and resistant animal species. J Infect Dis. 1947;80:1-13.
45. Gleiser CA, Gochenour WS, Ward MK. Pulmonary lesions in dogs and pigs exposed to a cloud of anthrax spores. J Comp Pathol. 1968;78:445-449.
46. Lebowich RJ, McKillip BG, Convoy IR. Cutaneous anthrax - a pathologic study with clinical correlation. Am J Clin Pathol. 1943;13:505-515.
47. Lincoln RE, Walker JS, Klein F, Rosenwald AJ, Jones WI. Value of field data for extrapolation in anthrax. Fed Proc. 1967;26:1558-1562.
48. Friedlander AM. Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process. J Biol Chem. 1986;261:7123-7126.
49. Hanna PC, Acosta D, Collier RJ. On the role of macrophages in anthrax. Proc Natl Acad Sci USA. 1993;90:10198-10201.
50. Beutler B, Milsark IW, Cerami A. Passive immunization against cachectin/ tumor necrosis factor protects mice from lethal effects of endotoxin. Science. 1985;229:869-871.
51. Tracey KJ, Beutler B, Lowry SF, et al. Shock and tissue injury induced by recombinant human cachectin. Science. 1986;234:470-474.
52. Tracey KI, Fong Y, Hesse DG, et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteremia. Nature. 1987;330:662-664.
53. Bauer KA, ten Cate H, Barzegar S, Spriggs DR, Sherman ML, Rosenberg RD. Tumor necrosis factor infusions have a procoagulant effect on the hemostatic mechanism of humans. Blood. 1989;74:165-172.
54. Grau GE, Piguet PF, Vassalli P, Lambert PH. Involvement of tumour necrosis factor and other cytokines in immune-mediated vascular pathology. Int Arch Allergy Appl Immunol. 1989;88:34-39.
55. Risberg B, Andreasson S, Eriksson E. Disseminated intravascular coagulation. Acta Anaesthesiol Scand. 1991;suppl 95:60-71.
56. Semeraro N, Colucci M. Changes in the coagulation-fibrinolysis balance of endothelial cells and mononuclear phagocytes: role in disseminated intravascular coagulation associated with infectious diseases. Int J Clin Lab Res. 1992; 21:214-220.
57. Walker JS, Lincoln RE, Klein F. Pathophysiological and biochemical changes in anthrax. Fed Proc. 1967;26:1539-1544.
58. Vessal K, Yeganehdoust J, Dutz W, Kohout E. Radiologic changes in inhalation anthrax a report of radiological and pathological correlation in two cases. Clin Radiol. 1975;26:471-474.
59. Brachman PS, Pagano JS, Albrink WS. Two cases of fatal inhalation anthrax, one associated with sarcoidosis. N Engl J Med. 1961;265:203-208.